Amniotic Mesenchymal-Derived Extracellular Vesicles and Their Role in the Prevention of Persistent Post-Breeding Induced Endometritis

Int J Mol Sci. 2023 Mar 8;24(6):5166. doi: 10.3390/ijms24065166.

Abstract

Persistent post-breeding induced endometritis (PPBIE) is considered a major cause of subfertility in mares. It consists of persistent or delayed uterine inflammation in susceptible mares. There are many options for the treatment of PPBIE, but in this study, a novel approach aimed at preventing the onset of PPBIE was investigated. Stallion semen was supplemented with extracellular vesicles derived from amniotic mesenchymal stromal cells (AMSC-EVs) at the time of insemination to prevent or limit the development of PPBIE. Before use in mares, a dose-response curve was produced to evaluate the effect of AMSC-EVs on spermatozoa, and an optimal concentration of 400 × 106 EVs with 10 × 106 spermatozoa/mL was identified. At this concentration, sperm mobility parameters were not negatively affected. Sixteen susceptible mares were enrolled and inseminated with semen (n = 8; control group) or with semen supplemented with EVs (n = 8; EV group). The supplementation of AMSC-EVs to semen resulted in a reduction in polymorphonuclear neutrophil (PMN) infiltration as well as intrauterine fluid accumulation (IUF; p < 0.05). There was a significant reduction in intrauterine cytokine levels (p < 0.05) for TNF-α and IL-6 and an increase in anti-inflammatory IL-10 in mares in the EV group, suggesting successful modulation of the post-insemination inflammatory response. This procedure may be useful for mares susceptible to PPBIE.

Keywords: endometritis; mare; polymorphonuclear neutrophil infiltration; regenerative medicine; uterine fluid accumulation.

MeSH terms

  • Animals
  • Anti-Inflammatory Agents / pharmacology
  • Disease Susceptibility
  • Endometritis* / prevention & control
  • Endometritis* / veterinary
  • Female
  • Horse Diseases* / prevention & control
  • Horses
  • Humans
  • Insemination, Artificial / methods
  • Insemination, Artificial / veterinary
  • Male
  • Semen

Substances

  • Anti-Inflammatory Agents

Grants and funding

This research was funded by MASTOP funding Italy (Regione Lombardia, Operazione 1.2.01. d.d.s. n°11297/2016 Project number: RL_DG-AGR17FCREM_01), and by the Università degli Studi di Milano.